(RS)-KETOPROFEN
Hepato-cellular Carcinoma
Iuliu Hatieganu University of Medicine and PharmacySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
2 Active assets in the Hepato-cellular Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
NEPENTHE Iuliu Hatieganu University of Medicine and Pharmacy | N/A | D |
Nefopam Iuliu Hatieganu University of Medicine and Pharmacy | N/A | D |
Same molecule, other indications
(RS)-KETOPROFEN is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →